Abbott Laboratories' second-quarter revenue from diagnostics climbed to $1.99 billion, with U.S. diagnostics sales rising 23% to $857 million in the quarter. "Abbott Beats Forecasts on Strong Covid-19 Testing Business," published at 7:49 a.m., misstated total diagnostics revenue rose 23% to $857 million.

(END) Dow Jones Newswires

July 16, 2020 08:37 ET (12:37 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Abbott Laboratories Charts.